The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives

L.P. Shulman

doi:10.1016/j.ajog.2011.06.057

The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives

L.P. Shulman

In: American Journal of Obstetrics and Gynecology · 2011 · vol. 205(4) , pp. S9–S13 · doi:10.1016/j.ajog.2011.06.057 · PMID:21961825 · W2031839933

review OA: closed CC0 ⤵ 2 in-corpus citations

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This paper reviews the benefits and risks associated with combined estrogen and progestin contraceptives.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

Cited by (2)

References (36)

Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel via openalex
Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest via openalex
Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies via openalex
doi:10.1016/s0029-7844(02)02124-5 via openalex
doi:10.1016/j.ogc.2021.07.001 via openalex
doi:10.2307/1966452 via openalex
doi:10.1136/bmj.b2921 via openalex
doi:10.1097/01.aog.0000279448.62221.a8 via openalex
doi:10.1016/s0029-7844(99)00524-4 via openalex
doi:10.1067/mob.2002.121103 via openalex
doi:10.1016/j.contraception.2009.07.004 via openalex
doi:10.1136/bmj.b2890 via openalex
doi:10.3109/13625187.2010.504313 via openalex
W2064528665 via openalex
doi:10.2165/00003088-200039030-00005 via openalex
W2284147024 via openalex
doi:10.1097/01.aog.0000250968.82370.04 via openalex
W6679100095 via openalex
W6683816966 via openalex
W6695611674 via openalex
doi:10.1016/s0015-0282(99)00205-8 via openalex
doi:10.1016/j.mce.2003.10.030 via openalex
doi:10.1016/s0015-0282(01)03275-7 via openalex
doi:10.1016/j.fertnstert.2008.08.093 via openalex
doi:10.1016/s0015-0282(00)01747-7 via openalex
doi:10.1016/s0015-0282(01)03263-0 via openalex
doi:10.1016/j.contraception.2005.03.005 via openalex
doi:10.1016/j.contraception.2004.12.012 via openalex
doi:10.1136/bmj.39289.649410.55 via openalex
doi:10.1016/j.contraception.2006.01.001 via openalex
doi:10.1097/aog.0b013e31818425b7 via openalex
doi:10.1016/j.contraception.2009.09.009 via openalex
doi:10.1016/j.contraception.2006.12.019 via openalex
doi:10.1097/00006250-200209000-00030 via openalex
doi:10.1016/0010-7824(96)00137-0 via openalex
doi:10.1016/s0002-9378(98)70047-x via openalex

Cited by (2)

Source provenance

openalex: last seen: 2026-05-11T06:25:09.493344+00:00

License: CC0 · commercial use OK

[1] Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel 2009

[2] Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies 2008

[3] Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest 2010